Trial Profile
Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis Grant Number: R34HL122558
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Aug 2021
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Bortezomib (Primary) ; Mycophenolate mofetil (Primary)
- Indications Systemic scleroderma
- Focus Adverse reactions
- 02 Aug 2021 Status changed from recruiting to completed.
- 03 Sep 2019 Planned End Date changed from 1 Jun 2019 to 1 Jun 2020.
- 03 Sep 2019 Planned primary completion date changed from 1 Jun 2019 to 1 Jun 2020.